Related Experiment Video
Updated: Apr 19, 2026
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Bystander effects in both hypoxic cancer and normal cells under FLASH irradiation using proton microbeams
Narongchai Autsavapromporn1, Taisei Mamiya2,3, Cuihua Liu4
1Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Purpose:
Emerging evidence supports that ultra-high dose rate (UHDR) FLASH irradiation spares normal tissues while preserving tumor control. However, the mechanisms of radiation-induced bystander effects (RIBE) in both cancer and normal cells under hypoxic conditions following FLASH proton microbeam irradiation remain poorly understood.
Material And Methods:
In this study, confluent A549 lung cancer cells and TIG-1 normal lung fibroblasts were irradiated with a total dose of 10 Gy using a proton microbeam at dose rates of 23 or 920 Gy/s under hypoxic conditions.
Results:
A sparing effect was observed in both hypoxia-treated bystander cancer and normal cells following FLASH irradiation, suggesting a protective response. Gap junction intercellular communication (GJIC) is mediated by the connexin trend of reducing radiation-induced toxicity in hypoxia-treated bystander cancer and normal cells, indicating a protective effect of GJIC suppression. The protective effect of FLASH irradiation was more evident in normal cells compared to cancer cells under hypoxia, potentially due to differences in nuclear factor erythroid 2-related factor 2 (Nrf2) activity, a major regulator of antioxidant defense.
Conclusions:
These observations enhance current knowledge of the mechanisms mediating biological effects of FLASH irradiation and may support the development of optimized RT strategies to minimize treatment-associated toxicity, thereby enhancing the therapeutic ratio in cancer treatment.
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:59Biological Effects of Radiation